Trial Profile
A clinical study to evaluate the correlation between the efficacy and the immunological markers in patients with rheumatoid arthritis treated with Tofacitinib.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jan 2019
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 23 Jan 2019 Status changed from recruiting to completed.
- 26 May 2016 New trial record